Telerehabilitation Early After Stroke

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to assess the safety and feasibility of providing extra doses of rehabilitation therapy for persons with a recent stroke. The therapy treatment targets to improve arm function by introducing telerehabilitation to the bedside of participants during the inpatient rehab admission period. Participants will use a newly developed functional training system (HandyMotion) to access therapy treatment program directly from their hospital room. HandyMotion is a sensor-based training system that can connect to the TV set in the hospital room, enabling patients to access their therapy training program to practice rehab-oriented games and exercises ad libitum, at any time of the day.

Clinical Trial Description

This clinical trial is designed to address 3 specific aims: Aim 1: To measure the safety of daily bedside telerehabilitation. Aim 2: To measure the feasibility of daily bedside telerehabilitation. Aim 3: To derive a preliminary estimate of motor and functional outcomes in patients engaged in daily bedside telerehabilitation. Telerehabilitation therapy is delivered over the course of the inpatient rehabilitation stay. A therapist-facing web portal is used for treatment planning and patient monitoring. The treatment approach was initially designed based on an upper-extremity task-specific training manual and Accelerated Skill Acquisition Program. Each daily 45-minute treatment session is created by a licensed OT or PT and includes: A. At least 15 min/day of upper extremity exercises. In addition, therapists have the option to incorporate standard exercise equipment (e.g., Theraband or dowels) that can be incorporated into assigned exercises. B. At least 15 min/day of functional training through games. The study provides 2 controllers with 5 different input devices that are available to drive game play. Games stress various motor control features (e.g., varying movement speed, range of motion, target size, extent of visuomotor tracking, or level of cognitive demand), which are selected and adjusted by the therapist. C. Five minutes/day of stroke education. The education content targets five categories (Stroke Risk Factors, Stroke Prevention, Effects of Stroke, Diet, and Exercise) and corresponds to the Stroke Knowledge Exam. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05625438
Study type	Interventional
Source	TRCare, Inc.
Contact	Johnson K Sun
Phone	650-300-2168
Email	kit@trcare.net
Status	Recruiting
Phase	N/A
Start date	December 19, 2022
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03281590` - Stroke and Cerebrovascular Diseases Registry
Recruiting	`NCT05591183` - CERENOVUS Neurothrombectomy Devices Registry
Recruiting	`NCT03685578` - CERENOVUS Neurothrombectomy Devices Registry
Completed	`NCT04465019` - Exoskeleton Rehabilitation on TBI
Completed	`NCT02827825` - Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
Recruiting	`NCT02077582` - Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability	N/A
Completed	`NCT01732679` - Sunnaas International Network´s Stroke Study	N/A
Terminated	`NCT01705353` - The Role of HMGB-1 in Chronic Stroke	N/A
Completed	`NCT01182818` - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease	N/A
Completed	`NCT00311025` - Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications?	Phase 1/Phase 2
Withdrawn	`NCT03804125` - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Completed	`NCT05435404` - Qualitative Study Patient & Physician Experiences Botox COVID-19
Completed	`NCT03898960` - Post Marketing Study to Evaluate the NIMBUS Device
Not yet recruiting	`NCT06087094` - A Trial of HRS-7450 in Chinese Healthy Volunteers	Phase 1
Completed	`NCT02207023` - Healthy Lifestyles After Stroke - Stroke Coach	N/A
Active, not recruiting	`NCT02017574` - Motor Learning in Stroke	Phase 0
Completed	`NCT02002390` - Efficacy and Safety of FTY720 for Acute Stroke	Phase 2
Completed	`NCT01864382` - "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients	N/A
Recruiting	`NCT04447599` - Conjunctival and Retinal Vascularization and Small Vessel Disease	N/A
Recruiting	`NCT04157179` - Cerebral Oxygen Metabolism in Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.